Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial

• Steff C. Lewis,

  Affiliation Centre for Population Health Sciences, University of Edinburgh, Edinburgh, Lothian, United Kingdom

  ⨯
• Siladitya Bhattacharya,

  Affiliation Applied Health Sciences, University of Aberdeen, Aberdeen, Grampian, United Kingdom

  ⨯
• Olivia Wu,

  Affiliation Health Economics and Health Technology Assessment Institute of Health and Wellbeing, University of Glasgow, Glasgow, Lanarkshire, United Kingdom

  ⨯
• Katy Vincent,

  Affiliation Nuffield Department of Obstetrics and Gynaecology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• Stuart A. Jack,

  Affiliation Gynaecology, Aberdeen Royal Infirmary, Aberdeen, Grampian, United Kingdom

  ⨯
• Hilary O. D. Critchley,

  Affiliation MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, Lothian, United Kingdom

  ⨯
• Maureen A. Porter,

  Affiliation Applied Health Sciences, University of Aberdeen, Aberdeen, Grampian, United Kingdom

  ⨯
• Denise Cranley,

  Affiliation MRC Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, Lothian, United Kingdom

  ⨯
• John A. Wilson,

  Affiliation Department of Anaesthesia and Pain Medicine, Royal Infirmary of Edinburgh, Edinburgh, Lothian, United Kingdom

  ⨯
• Andrew W. Horne

  * E-mail: andrew.horne@ed.ac.uk

  Affiliation MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, Lothian, United Kingdom

  ⨯